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Background: Immunological memory is 
maintained by antigen independent tonic 
stimulation. 
Results: Stress-treated dendritic cells stimulate 
IL-15 and IL-1β mediated pathways, required 
for optimum memory T cell induction. 
Conclusions: Stress agents may be responsible 
for the persistence of immunological memory, 
involving an epigenetic mechanism. 
Significance: Repetitive stress may account for 
tonic stimulation, which maintains 
immunological memory. 
 
The prevailing evidence suggests that 
immunological memory does not require 
antigenic re-stimulation but is maintained by low 
level tonic stimulation.  We examined the 
hypothesis that stress agents contribute to the 
tonic cellular activation and maintain 
immunological memory. Stimulation of 
monocyte derived dendritic cells (DC) with 
stress agents elicits reactive oxygen species and 
HSP70. NFκB is activated, which upregulates 
membrane associated (ma) IL-15, caspase-1 and 
IL-1β. Co-culture of stress-treated DC with 
mononuclear cells activates IL-15 and IL-1β 
receptors on CD4+ T cells, eliciting CD40L, 
proliferation and upregulation of CD45RO+ 
memory T cells.  The transcription factors 
Tbethigh and RORγt are upregulated, whereas 
FoxP3 is downregulated, resulting in enhanced 
Th1 and Th17 expression and the corresponding 
cytokines. The interaction between maIL-15 
expressed by DC and IL-15R on CD4+ T cells 
results in one pathway and the corresponding 
cells expressing IL-1β and IL1βR a second 
pathway.  Importantly, inhibition studies with 
IL-15 antibodies and IL-1βR inhibitor suggest 
that both pathways may be required for optimum 
CD4+ CD45RO+ memory T cell expression. 
Type 1 IFN expression in splenic CD11c DC of 
stress-treated mice demonstrated significant 
increase of IFN-α in CD11c CD317+ and CD8α+ 
DC. Analysis of RNA in human CD4+ memory 
T cells showed upregulation of type 1 IFN 
stimulated genes and inhibition with histone 
methyl transferase inhibitor. We suggest the 
paradigm that stress-induced tonic stimulation 
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might be responsible for the robust persistence 
of the immune response in vaccination and that 
epigenetic changes are involved in maintaining 
CD4+ T cell memory. 
 
Immunological memory is an essential 
feature of an effective vaccine. There is 
compelling evidence that memory T cells do not 
require antigen-stimulated MHC-TCR 
interaction to survive (1,2). The robust smallpox 
vaccine efficacy is the best example of life-long 
memory without further antigenic stimulation 
(3).  However, the mechanism of maintenance of 
immunological memory has not been elucidated, 
despite its immense significance in the field of 
preventive immunization. It has been argued that 
maintenance of immunological T-cell memory 
may involve low-level antigen-independent T-
cell homeostatic division in lymphoid tissues (4-
6). This maintains a stable CD4+ memory T-cell 
population as demonstrated with smallpox 
vaccination. We have examined the hypothesis 
that repetitive TCR-independent activation by 
cellular stress may account for the low level 
signalling maintaining immunological memory 
and that epigenetic changes might be involved. 
         In humans thermal or oxidative stress 
studies in vitro (7) and in vivo experiments in 
BALB/c mice (8) demonstrated that stress agents 
activating antigen - TCR independent interaction 
between DC and CD4+ T cells, may be 
responsible for maintaining the homeostatic 
CD4+ T cell memory. HSP70 expression is the 
hallmark of a stress response, which functions as 
an endogenous danger signal to the immune 
system (9,10). Oxidative stress is induced by 
free radicals of ROS (reactive oxygen species), 
which may stimulate DC to release glutathione, 
which is broken down to cysteine and enables T 
cells to maintain redox homeostasis (11). ROS 
affects the innate immune system through 
attraction of polymorphonuclear leukocytes 
(PMNS), monocytes and macrophages, which  
control microorganisms, and toll-like receptors 
may be involved (12,13). ROS also functions in 
adaptive immunity regulating T cell proliferation 
(14), activating NFκB (15).  Furthermore, 
mitochondrial ROS may activate the 
inflammasome pathway (16). The biological and 
biochemical complexities of oxidative stress and 
their functions have been extensively reviewed 
recently (17). 
 
Human  DC-CD4+ T cell interactions can be 
stimulated by heat, oxidative stress agents, 
Gramicidin (K releasing agent) or  
dithiocarbamate a metal ionophore, leading to 
NFκB maIL-15 expression (7,8). The latter 
ligates the IL-15R complex on CD4+ T cells and 
induces CD40L expression, T-cell proliferation, 
and IFN-γ production (7). Intracellular stress 
sensors activate inflammasomes and the 
production of IL-1β (18,19). Metabolic stress is 
also associated with NLRP3 inflammasomes in 
type 2 diabetes (20) but can be independent of 
inflammasomes (21). Intracellular sensors 
involve  NLR (nucleotide-binding  
oligomerization domain-like receptors), which 
sense endogenous danger signals (22),  released 
from damaged or necrotic cells, such as HSP70, 
termed damage-associated molecular patterns 
(DAMPs).  
 The aim of this paper was to study the 
effect of a number of diverse stress agents on the 
interaction between maIL-15 expressed by DC 
and IL-15R on CD4+ T cells in one pathway and 
the corresponding cells expressing IL-1β and IL-
1β R in a parallel pathway. The results suggest 
that stress activates the two pathways and both 
are required for optimum CD4+CD45RO+ 
memory T cells. Furthermore, we studied type 1 
IFN expression in 3 subsets of splenic DC from 
BALB/c  mice treated with the same stress 
agents and Alum, which demonstrated 
significant   increase of IFN-α  in the CD317+ 
DC and to a lesser extent in the CD11/c CD8+ 
DC.    The transcription factors RORγt  and Tbet 
IFN-γ were significantly upregulated in memory 
T cells, eliciting Th17 and Th1 cells, 
respectively and the corresponding cytokines, 
whereas FoxP3 expression was downregulated. 
Gene expression of CD4+ CD45RO+ memory T 
cells was studied using Illumina and validated 
by Affymetrix unbiased microarray analysis. 
The data demonstrate transcriptional 
upregulation of type 1 IFN stimulated genes 
(ISG), which may be critical both for modulating 
immune responses and for control of viral 
infections. 
Experimental Procedures 
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Stress agents used to stimulate monocyte 
derived dendritic cells 
Three different agents were used to induce stress 
in DC. Na arsenite was selected as it is an 
oxidative agent, Gramicidin induces K efflux, 
Dithiocarbamate is an ionophore and Alum is 
the most common clinically used adjuvant, with 
characteristics of a stress agent (7,8).  The 3 
stress agents were all purchased from Sigma, 
and Alum from Serva electrophoresis GmbH. 
Human CD14+ monocytes were prepared from 
PBMC (obtained from the National Blood 
Service) by either enriching by depletion of 
CD14- cells using Monocyte Isolation Kit 
(MACS, Miltenyi Biotec) or positively selected 
by antibody to CD14 using the “panning” 
method. The isolated CD14+ monocytes were 
cultured in GM-CSF (800 U/ml) and IL-4 (20 
U/ml) supplemented medium for 4-5 days to 
differentiate into immature dendritic cells. 
Immature DC (2x105/ml) were incubated with 
increasing concentrations of stress agents. After 
90 min at 37°C, the cells were washed 3 times 
and used in comparison with untreated cells.  
Assay of ROS 
Assay of ROS was carried out by using Image-
iT live green ROS detection kit (Molecular 
Probes, Invitrogen). DC were treated with 
increasing concentrations of Na arsenite, 
Gramicidin, dithiocarbamate or 1mg/ml of alum 
for 5-30 min in RPMI culture medium, 
supplemented with 10% FCS. After incubation, 
carboxy-H2DCFDA was added to the cells to a 
final concentration of 25 µM. Following further 
30min incubation, the samples were analyzed by 
flow cytometry.  
Real time PCR for HSP70 mRNA 
Aliquots of 1x106 untreated and stress treated 
DC were incubated overnight, the RNA isolated 
with the Total RNA Isolation Kit (Promega, 
Southampton, UK) and quantified by using the 
spectrophotometer (GeneQuant II, Pharmacia 
Biotech). cDNA was generated from RNA by 
using the Reverse Transcription System 
(Promega), according to the manufacturer’s 
instructions. The primers for human HSP70 and 
GAPDH were synthesized by Sigma (UK). 
Relative amount of HSP70 mRNA was 
quantified by real-time PCR (ABI Prism 5700), 
using the PlatinumSYBR green qPCR 
SuperMix- UDG with ROX (Invitrogen Life 
Technologies), as described previously.  The 
results were expressed as fold increase over 
control RNA.  
Gating strategy of flow cytometry 
Flow cytometry was carried out on BD 
FacsCantoTM II, using DIVA software and data 
analysis used WinMDI 2.8 software. The gating 
strategies used in this study are shown in Fig.2. 
(A) for cell surface molecule staining the live 
lymphocyte population was gated and confirmed 
by 7AAD negative staining. CD4+ T cells were 
then gated for cell surface molecules and/or 
memory cell. (B) For intracellular staining, cells 
were stained for cell surface markers before 
fixation and permeabilization. The lymphocyte 
population was then gated, CD4 naïve and 
CD45RO+ memory T cells were identified and 
the intracellular proteins examined within 
identified CD4+ or CD45RO+ central (CCR7+) or 
effector (CCR7-) memory T cells. (C) Culture of 
DC or (D) DC cocultured with isolated CD4+ T 
cells were gated based on FSC and SSC and 
these populations were examined for either cell 
surface or intracellular molecules. 
Assay of maIL-15, IL-15Rα and HSP70  in 
DC by flow cytometry 
Cell surface expression of IL-15 or HSP70 on 
monocytes derived DC without or with treatment 
by stress agents were determined by flow 
cytometry. Cells were incubated with 10 µl 
(10µg/ml) of  PE conjugated  anti-HSP70 or 10 
μl (100μg/ml, Strassgene) of APC conjugated 
anti-human IL-15 mAb for 30min. After 
washing cells were then analysed by  flow 
cytometry. 
For intracellular HSP70 staining DC were 
treated with fixation buffer (eBiosciences, 
London) and permeabilized with 
permeabilization buffer (eBiosciences).  
Intracellular HSP70 was then stained with the 
anti-HSP70 mAb. In some experiments, ROS 
inhibitor NAC (N-acetylcystein) was added to 
the stress treated DC in order to study the effect 
of ROS on HSP70 or IL-15 production. 
Assay of inflammasome molecules, cytokines 
and the receptors 
Caspase-1 activation in DC was identified by 
using FAM-FLICA caspase-1 kit (ABD serotec). 
Cultured DC (2x104 per well) in 96-well plates 
were incubated with 20 µl of 1:300 diluted 
FAM-YVAD-FMK for 1 hour at 37°C. After 
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washing, the cells were analysed by flow 
cytometry.  For IL-1β assay, DC (2x104 in 100 
μl per well) in 96-well plates were treated with 
various stress agents in the presence of 10ng/ml 
of LPS. After 18 hours incubation, the 
supernatants were collected and IL-1β was 
assayed using human IL-1β ELISA set (BD 
OptEIATM). The ROS inhibitor NAC was used 
as above in caspase 1 and IL-1β production. 
CD4+ T cells (2x105 per well) were co-cultured 
in U-bottom 96 well-plates with 2x104 stress-
treated DC. After 5 days incubation, culture 
supernatants were collected and these were used 
in ELISA kits to detect IL-12p40 (BD 
OptEIATM), IL-12p70(BD OptEIATM), IL-6 
(Ready-Set-Go, eBiosciences) and TGF-β 
(Ready-Set-Go, eBiosciences).Expression of the 
cytokine receptors IL-1R, IL15Rα and IL-6R  in 
CD4+ T cells was also analysed by flow 
cytometry following co-culture of stress treated 
DC with PBMC. 
Co-culture of DC with autologous monocyte–
depleted PBMC and analysed for CD4+ 
memory T cells, CD40L and cytokines 
Aliquots of 2x105 PBMC per well or isolated 
CD4+ T cells in U-bottom 96 well-plates were 
co-cultured with 2x104 stress-treated DC in a 
total volume of 200µl per well. After 5 days 
CD4+ T cells were analysed for CD45RO+, 
central CD45RO+CCR7+ and effector 
CD4+45RO+CCR7- memory markers, using 
mAb to CD45RO and CCR7 (both from 
Biolegend). For detection of cell surface CD40L, 
5μl of FITC-conjugated mAb to CD40L or 
isotype control antibody (BD Biosciences, BD 
Europe) was added to the culture and incubated 
for 4 hours. For IFN-γ staining, Golgistop (0.7 
μg/ml, BD Biosciences) was added 4 hours 
before termination of the co-culture and the cells 
were fixed for 10 min with 100 μl of Fixation 
buffer and permeabilized with 1ml of 
Permeabilization Buffer. The cells were then 
washed twice and stained with 5μl of antibody to 
(PE)-conjugated anti-IFN-γ for 30 min at room 
temperature in 45 μL Perm/Wash solution. The 
cells were then characterised by flow cytometry. 
To study the effect of stressed DC on IL-17 
production, LPS treated mature DC were used 
and treated with the stress agents. In addition, 
PBMC were stimulated with antibodies to CD3 
and CD28 (1μg/ml each). After 5 days culture, 
cells were fixed and permeablized and 
intracellular IL-17 was detected with PE 
conjugated antibodies to IL-17. 
Inhibition studies of human CD4+ T cells 
To ascertain whether the H (IL-15-mediated) or 
I (IL-1β mediated) or both pathways are 
involved in eliciting CD40L and CD45RO+ 
memory T cells, co-cultures of DC and PBMC 
were treated with either 10µg/ml anti IL-15 
neutralizing antibodies (R&D Systems) 50 µM 
of IL-1β receptor I antagonist (IL-1β RI, Merck) 
or both were used with previously determined 
optimum doses of inhibitors. After 5 days 
incubation the cells were examined for CD40L 
expression by flow cytometry. Similarly, 
CD45RO+ CD4+ memory T cells and the CCR7+ 
or CCR7- subsets were assayed by flow 
cytometry.  
Examination of transcription factors Tbet, 
GATA3, RORγt and FoxP3 
DC were stimulated with stress inducing agents 
and co-cultured with PBMC for 1-5 days. After 
cell surface staining intracellular expression of 
T-bet, GATA-3 and RORγt in CD4+ T cells or 
CD45RO+ memory T cells were stained with the 
respective fluorochrome conjugated antibodies 
of antibodies to CD3 (1μg/ml) and CD28 
(1μg/ml). After 5 days co-culture, cells were 
fixed and permeablized and intracellular Foxp3 
was detected with PE conjugated antibodies to 
Foxp3 (Biolegend, UK). 
RNA Microarray studies 
RNA was prepared from CD4CD45RO+ memory 
T cells by the FACSArial cell sorter to >95% 
purity, following co-culture for 5 days of PBMC 
(2x106 per ml) with 2x105 untreated DC or 
Gramicidin-treated DC (5µg/ml), without or 
with 200µM MTA. RNA was isolated using 
Qiagen Allprep kit. 50ng RNA was amplified 
using NuGEN Applause 3’-Amp system and 
labelled with NuGEN Encore BiotinIL module. 
cDNA was hybridized to Illumina HT12v4 
arrays and these were scanned using Illumina’s 
iSCAN platform.  Array data was subjected to 
quantile normalization using Illumina Genome 
Studio and exported for analysis within Partek 
Genomics Suite (Partek, St Louis, Mo) by using 
the gene expression workflow to identify 
differentially expressed genes.  Briefly, robust 
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multichip average pre-processing was 
performed, and genes differentially expressed 
were identified by using the Partek ANOVA 
model.  This data were then validated by the 
Affymetrix system.  RNA was extracted using 
Total RNA Isolation Kit (Promega, 
Southampton, UK) and quantified using 
NanoDrop 2000c (Thermo Scientific). The RNA 
was amplified using the MessageAmp Premier 
RNA Amplification Kit (Ambion), fragmented, 
then hybridized onto U133 2.0 gene chips 
(Affymetrix). Chips were scanned (Affymetrix 
GeneChip Scanner 3000) and checked using 
Affymetrix Command Console (AGCC) 
software suite). These data was statistically 
analysed using Qlucore Omics Explorer v2.3. 
Gene Ontology analysis was performed using 
MetaCore (version 2.4, GeneGo Inc.). 
The effect of treatment of the CD4+CD45RO+ 
memory T cells with the histone methyl 
transferase inhibition (MTA) 
To study the potential effect of epigenetic 
changes on T cell activation, MTA was used in 
the co-culture system.  CD4+ T cells (2x105 per 
well) were co-cultured in U-bottom 96 well-
plates with 2x104 stress-treated DC in the 
presence of 100 or 200 µM MTA.  After 5 days 
culture intra-cellular expression of IL-17 and 
IFN-γ were assayed, as described above. Ιn some 
experiments CD4+CD45RO+ cells were isolated 
from the co-culture, using the memory cell 
separation kit (MACS), total RNA was  prepared 
as described above and mRNA for HSP70, IL-17 
and IFN-γ assayed by real-time PCR. 
Statistical analysis 
The in vitro experiments were repeated 3 or 
more times and the data are presented as the 
mean±sem. The significance between groups 
was analysed by F-ANOVA, followed by paired 
t test with selected groups, using the GraphPad 
Prism 5 Software. 
 
Results 
The effect of stress agents on ROS, HSP70  
mRNA, cell surface and intracellular HSP70 
in  DC 
ROS induce oxidative stress that leads to a state 
of redox equilibrium, which stimulates the P13K 
pathway to induce downstream IL-1β. ROS was 
assayed in human DC before and after treatment 
with Na arsenite (50µM), Gramicidin (2µM/ml), 
dithiocarbamate (1µM) and Alum (1%). All 
except alum yielded very significant increase in 
ROS production (p<0.001, Fig. 1A), from a 
baseline of 9.3% up to 86%; and representative 
flow cytometry is presented in Fig. 1B.  
Cellular stress elicits intracellular sensors and 
here we examined inducible HSP70 in human 
monocyte derived DC. We first analysed the 
proportion (and MFI) of intra-cellular HSP70, 
which were significantly upregulated with all 
test agents and maximally with dithiocarbamate 
(Fig. 1C,D; MFI is not presented). The 
production of intracellular HSP70 was broadly 
in line with that of ROS, except for alum, which 
failed to enhance ROS. However, cell surface 
HSP70 was significantly upregulated only with 
Gramicidin and Alum (Fig.1, E,F).  All stress 
agents significantly upregulated HSP70 mRNA 
(p<0.05-<0.01, Fig. 1G). Altogether, ROS was 
increased with the 3 stress agents in parallel with 
intra-cellular and mRNA HSP70 but not cell 
surface HSP70. Alum, however showed no 
effect on ROS, suggesting that a different 
mechanism is involved in upregulating HSP70. 
The gating strategies are shown in Fig.2A-D and 
for ease of following the DC - CD4 T cell 
interactions a flow sheet (Fig. 2E) . 
Stress-activated maIL-15 and inflammasomes 
Previous studies suggest that DC exposed to 
stress agents activate the NFκB pathway, which 
acts as a transcription factor for maIL-15 
molecules (7). Dose-dependent studies with 
increasing concentrations of Na arsenite, 
Gramicidin, dithiocarbamate  and Alum showed 
concentration-dependent increase of maIL-15 in 
DC ( Fig. 2A, D). These were consistent with 
our previous results using thermal and oxidative 
stress only (7).  IL-15Rα was upregulated from 
10.5+1.1% to 15.7+0.7% (p<0.01) when treated 
with Gramicidin but not with Na arsenite (data 
not presented). 
Stress agents stimulate the NLRP3 
inflammasomes (18-20) and here we 
demonstrate that stimulation of DC, elicited 
dose-dependent increase in caspase-1 activation 
and IL1β production with all stress agents and 
Alum (Fig. 3B, C). This is consistent with the 
data elicited in vivo in Balb/c mice, but when 
immunised with ovalbumin (8).  The dose-
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dependent effect of Alum-treated DC showed 
an increase in IL-1β, which differed from 
caspase-1 reaching a plateau with the lowest 
concentration of alum. Thus, both IL-15 and 
inflammasomes are activated by the stress 
agents, but whilst Alum also upregulates 
inlammasomes it differs in kinetics. 
Dependance of  IL-15, caspase-1 and IL-1β on 
ROS by inhibition with N-acetylcystein 
To determine whether maIL-15, caspase-1 and 
IL-1β production are dependent on ROS we 
used N-acetylcystein (NAC) inhibition. This 
showed significant inhibition of maIL-15 in cells 
treated with the 3 stress agents but not with 
alum, consistent with the expression of maIL-15 
being dependent on ROS (p<0.05-0.01, Fig.4A).  
Similar inhibition of caspase-1 and IL-1β 
expression with NAC was found with 
Gramicidin and dithiocarbamate  but not with 
alum (p<0.05-0.01, Figs.4 B,C) or Na arsenite 
(not shown).  The data suggest that two of the 
stress agents activating caspase-1 and inducing 
IL-1β mediated  pathway are at least partly 
dependent on ROS. However, although Alum 
stimulates maIL-15 and inflammasomes they are 
not ROS dependent. 
IL-15 and IL-1β mediated effect in co-culture 
of stress treated DC with CD4+ T cells 
DC expressing maIL-15 interact with the IL-15 
receptor complex on CD4+ T cells, which are 
upregulated following co-culture with stress 
treated DC and activate Jak3 and STAT5 
phosphorylation to induce CD40L (7). This 
study extended the data and showed significant 
increase in IL-1β, which bind IL-1βR1 
expressed by CD4+ T cells, and these are 
significantly increased (p<0.05) (Fig. 4 D,E). 
This was found only in CD4+CD45 RO+ 
memory but not CD45RO- naive T cells, treated 
with Gramicidin, dithiocarbamate or alum 
(p<0.05), compared with the untreated cells (Fig. 
4D).  
Functional effects by the stress agents on 
CD4+ T cell proliferation and expression of 
 CD40 L (CD154) 
CD4+ T cell proliferation was tested  by the 
CFSE method. Significant increase in 
proliferation was found with Na arsenite and 
Gramicidin (p=0.015-0.011, Fig 5A.), similar to 
that of control LPS-treated DC used to induce 
maturation of  DC . A smaller increase with 
Dithiocarbamate, however was not significant 
and Alum had no effect. The lack of stimulation 
of CD4+ T cells with Alum is consistent with it 
being a B cell adjuvant. CD4+ T cell responses to 
the stress agents, without activation by an 
antigen, is of considerable significance in 
enhancing the helper and adjuvant functions of 
these cells. These findings are consistent with 
both in vitro and in vivo murine studies (7,8). 
CD40L is upregulated by antigen stimulation but 
stress may have a similar function, as  all agents 
used significantly enhanced CD40L expression 
(p<0.01-p<0.001, Fig.5A). The role of IL-15 and 
IL-1β mediated  pathways  in CD4+ T cell 
activation was first examined by inhibition of 
CD40L expression. An increase of CD40L was 
blocked by anti-IL-15 antibodies (p<0.001, 
p<0.01, Fig. 5B) with all agents used and to a 
lesser extent with IL-1β RI antagonist, limited to 
Na arsenite and Gramicidin (P<0.01); 
representative flow cytometry is presented in 
Fig. 4B. With the combined inhibitors there was 
increased inhibition with each stress agent 
(p<0.001, p<0.01). These results suggest that 
both pathways can inhibit CD40L expression, 
but IL-15 may be more effective than the IL-1β 
pathway (Fig. 5 B,C). This potentially important 
finding suggests that CD40L expression may be 
antigen-independent and that both pathways may 
be involved. 
Are both pathways required to induce CD4+ 
CD45RO+ memory T cells 
The effect of stress activated DC  on the 
development of antigen – independent CD4+ 
CD45RO+ memory T cells was then  studied 
following co-culture  with autologous PBMC for 
5 days. All stress agents and alum upregulated 
CD45RO+ memory T cells, as compared with 
untreated DC (from 30+3.7), but only Na 
arsenite (51.8+2.0; p<0.05) and Gramicidin 
(53.0+3.4, p<0.05) reached significant levels 
(Fig. 5D).  Further examination of the two major 
memory subsets, central (CD45RO+ CCR7+) and 
effector (CD45RO+ CCR7-) CD4+ memory T 
cells showed significant increase in the effector 
memory T cells with Na arsenite (p<0.01) and 
dithiocarbamate, (p=0.01) but not Gramicidin or 
alum (Fig. 5D).  
To ascertain whether the both pathways are 
activated by the stress agents to elicit CD4 
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CD45RO+ T cells, the co-cultures were treated 
with either IL-15 antibodies or IL-1β receptor I 
(IL-1β RI) antagonist or both, using previously 
determined optimum doses of inhibitors. 
Whereas Na arsenite, dithiocarbamate or alum 
treated DC inhibited CD45RO+ CD4+ T cells 
with IL-15 antibodies, without or with IL-1βRI 
antagonist, Gramicidin showed significant 
inhibition only with the combined inhibitors, 
though each separately induced some inhibition 
(Fig. 5D). The CD4+ CD45RO+CCR7- effector 
memory T cells were inhibited significantly 
predominantly when treated with both inhibitors 
(Fig. 5E). These results suggest that to elicit 
optimal expression of CD45RO+ memory and 
CCR7- effector memory CD4+ T cells, both the 
H and I pathways may be engaged. The 
CD45RO- naïve CD4+ T cells were not affected 
by the two inhibiting agents (data not presented). 
These experiments raised the issue whether  cell 
to cell contact is essential between DC and 
CD4+ T cells  to induce memory cells. This was 
studied  with stress stimulated DC in parallel  
with DC-derived culture supernatant , each co-
cultured with CD4+ T cells, followed  by assay 
of  CD4+ T cell proliferation. Significant  
proliferation was found in co-cultures with DC 
(37.0 ±3.0 %), but not  with the culture 
supernatant (5.0±1%), suggesting that  CD4+ 
memory T cells are cell to cell contact 
dependent. 
The effect of stress agents on CD4+ T cell 
transcription factors 
We next examined the effect of stress on Th1, 
Th2, Th17 and Treg transcription factors. DC 
were treated with the stress agents for 90min, 
then co-cultured with CD4+ T cells for 5 days 
and examined for the 4 transcription factors in 
CD4+ T cells by flow cytometry. The Tbet 
transcription factor of Th1 CD4+ T cells showed 
significant increase with the 3 stress agents only 
if co-expressed with IFNγ (F=5.172, p=0.041, 
Fig. 6A), but not with Alum.  GATA3 failed to 
be upregulated (data not shown). However, 
RORyt, the transcription factor for Th17 CD4+ T 
cells was significantly upregulated (F=6.826, 
p=0.0004, Fig. 6B), as well as with each stress 
agent (p<0.05 and p<0.001);  Co-expression of  
Tbet with RORyt was also demonstrated 
(F=7.893, p=0.0002.Fig.6C). In contrast FoxP3 
transcription factor of CD25+ regulatory CD4+ T 
cells was significantly downregulated (F=5.225, 
p=0.0014, Fig.6D) with each stress agent 
(p<0.05-0.01). The flow cytometry for each of 
the 3 transcription factors is presented in Fig. 6 
E,F,G.  The net result of these findings is that 
Tbet and RORyt transcription of Th1 and Th17 
functions are enhanced by virtue of a decreased 
inhibitory effect of the FoxP3 regulatory 
activity. 
To facilitate reading the sequence of interactions  
a flow diagram is presented in Fig. 2E. 
 Cytokine production 
The cytokines corresponding to the transcription 
factors were then studied. The two subtypes IL-
12p40 and IL-12p70 showed significant 
enhancement when DC were co-cultured with 
PBMC and treated with the stress agents (Fig. 
7A); only IL-12 p70 is presented).   IL-17 was 
significantly upregulated only by Gramicidin 
and dithiocarbamate (Fig.7B). Untreated DC or 
CD4+ T cell culture supernatants, each produced 
very small quantities of IL-6, but co-culture of 
immature DC with CD4+ T cells (p<0.001) or 
treatment with stress (p<0.001, Fig. 7C) 
upregulated IL-6 compared with untreated cells. 
IL-6R in CD4+ T cells were also upregulated in 
co-cultures with DC (Fig.7D) but only with 
arsenite and Gramicidin. Low levels of TGFβ-1 
were found in CD4+ T cell culture supernatants, 
however significant increase was induced with 
Gramicidin or dithiocarbanate  co-cultured with 
PBMC (p<0.05; not presented).   
Microarray analysis 
The transcriptome of CD45RO + memory T cells 
(95% purity) stimulated by Gramicidin treated 
DC was studied by Illumina HT12v4 arrays 
(n=3) validated by the Affymetrix array (n=3) 
systems following 5 day cultures. The unbiased 
hierarchical clustering of the Illumina  arrays  
demonstrated  upregulation  of 4 groups of stress 
stimulated genes (Table 1) and a 5th group of 
repressed cholesterol genes (not presented). 
 Group 1 consisted of 47 ISG, with >1.5-fold 
increase of Gramicidin treated compared with 
untreated CD4+ memory T cells and shown in 
the heat map (Fig. 8A). Of the 47 ISG 37 
showed significant increase in the stress-
stimulated compared with the unstimulated DC 
(p<0.05-<0.01; Table 1A, C). 23 of the ISG 
were validated by the Affymetrix   platform 
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(Table 1, group A,B). Group 2 consisted of 
transcription genes, IRF1 and IRF7 (IFN 
regulatory factors), which are upstream 
regulators of many ISGs (also noted in Table 1, 
group 1A) and BATF3, a regulator of RORγt in 
Th17 cells (Table 1, Group 2). The NFκB gene 
involved in transcription of IL-15 in DC and 
activation of CD4+ T cells and Tbet in activation 
of Th1 cells were demonstrated only by the 
Affymetrix platform. Network analysis of the 
ISGs suggests that they are IRF1 and IRF7 
driven, with hubs at NFκB and ISG15, OAS and 
type 1 IFN.    
The 3rd group included 3 early complement 
system genes of the classical C1Q, C2 and 
alternative CFB pathways, which were 
significantly upregulated (Table 1, Group 3). 
The miscellaneous group 4 (Table 1, Group 4) 
included the signalling p38 (MAPK11) and Jak2 
(Janus kinase 2) gene, which provides a protein 
involved in the JAK/STAT signalling pathway.  
Finally as the stress agents used to stimulate DC 
activates K+ channel opening, we searched for 
channel genes. Surprisingly, whilst the KCNQ 
potassium channel was not identified, the 
chloride channel 7 gene (CLCN7) was 
significantly upregulated in the CD4 memory T 
cells (Table 1, Group 4).     
Examination of repressed genes revealed a 
cluster of 22 cholesterol regulated genes (not 
presented), which produced a network, with 
hubs at high and low density lipids (HDL and 
LDL) and INSIG1. Among these genes were 
CD1A and CD1B, which are MHC class 1-like 
antigen presenting molecules specialised in 
presenting lipid antigens, especially 
mycobacterial cell wall components to CD1 
specific T cells (23). Also repressed was CD1E, 
which facilitates loading lipids onto CD1B. 
The effect of stress on subsets of CD11c  DC 
and the expression of IFNα 
The microarray analyses of CD4 CD45RO+ 
memory T cells revealed significant increase  of 
type 1 ISGs. This raised the question whether 
type 1 IFN is also induced  by the stress agents. 
We have previously demonstrated  that maIL-15 
and IL-1β are upregulated  in CD11c+ splenic  
DC  when BALBc mice were treated with the 
stress agents and OVA [8].  We followed this 
strategy by analysing this effect on IFNα  
expression in 3 subsets  of CD11c+ DC (Fig.9 
A,C).The CD11c CD19+ and  CD317+ subsets 
were upregulated but significant levels were not 
reached probably because of large variation  in 
the 6 samples tested (Fig. E,G). However, IFNα  
was very significantly increased in the CD317+ 
subset (p<0.0005,Fig. 9 H), to a lesser extent in 
the CD8α+ subset (p<0.05, Fig 9D) but not in 
the CD19+ subset of CD11c+ DC. These are 
novel findings, in that stress agents upregulate  
IFNα  in plasmacytoid DC and CD8α+ DC, 
which may regulate immunological functions.  
Analysis of CD45RO+ memory T cells treated 
with the histone methyl transferase inhibitor 
We next examined the paradigm that stress 
might induce low level tonic signalling with 
epigenetic changes, which may be responsible 
for maintaining memory. We sought evidence 
for an epigenetic component mediated either by 
histone modification or by DNA methylation. To 
this end we co-cultured the Gramicidin treated 
and untreated DC with PBMC, some of which 
were further treated with 5-deoxy-5-
methylthiodenosine (MTA) a protein 
methyltransferase inhibitor which inhibits both 
arginine (24) and lysine methylation of histone 
H3 (25). Treatment of CD4+, T cells with 
Gramicidin significantly increased IFN-γ, IL-17 
cytokines  and HSP70 mRNA (Fig. 8 B,C,D), or 
protein  expression (Fig. 8 E,H), which was 
inhibited  with MTA. This was observed only 
with CD45RO+ memory T cells but not with the 
CD45RO- naïve T cells (Fig. 8 F-J). Microarray 
analysis of the effect of MTA on the 
CD4+CD45RO+ memory T cells showed that 
14/23 of the Affymetrix tested ISG that  were 
upregulated >1.5-fold with Gramicidin were also 
downregulated >1.5-fold by MTA ( Table 1A, 
B). We suggest that short term culture with a 
stress agent may influence the chromatin 
environment and elicit epigenetic changes. 
 
 
Discussion 
We studied parallel induction of the IL-15/IL15-
R and Il-1β/IL1βR pathways  by co-culture  
stress activated DC with autologous  CD4+ T 
cells. Stress-induced ROS may activate HSP70 
an intra-cellular sensor molecule. A flow sheet 
illustration of the effect of stress on the 
interactions between DC and CD4+ T cells 
leading to CD4+CD45RO+ memory T cells, 
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cytokines and ISGs  shown in Fig. 2 E.  The 
stress agents upregulate inducible HSP70, which 
binds CD40, activating NFκB, inducing among 
others transcription of  IL-15 in DC. We have 
demonstrated previously that stress-mediated 
maIL-15 in DC binds  and activates the IL-15R 
complex on CD4+ T cells (8).  In parallel the 
inflammasome NLRP3 pathway is stimulated, 
activating caspase-1, which produces pro-IL-1.   
Both pathways can activate Jak3 and STAT5 
phosphorylation  in CD4+ T cells and induce 
CD40L in CD4+ T cells, which may reactivate 
CD40 molecules on DC and create a positive 
feed-back loop (7). CD40L (CD154) expression 
is commonly activated by antigens (26,27) but 
here we demonstrate an antigen independent 
effect  stimulated by stress agents.  
Investigation of key lineage-determining 
transcription factors in CD4+ T cells showed 
upregulation of Tbet co-expressed with IFNγ 
and RORγt  when DC were stimulated with the 
stress agents. Tbet regulates Th1 cytokines and 
RORγt  Th17 cell differentiation. GATA3 
transcription factor promotes Th2 cell 
differentiation but was not affected by the stress 
agents. Since the regulatory FoxP3 transcription 
factor of CD4+ T cells is significantly 
downregulated, the net effect is to enhance the 
immune functions. 
The critical question raised by these 
results was whether both pathways are required 
to elicit CD4+CD45RO+ memory T cells. IL-15 
has been well recognized to be significantly 
involved in antigen-independent CD4+ and CD8+ 
memory T cells (28-33) . Our previous studies 
also demonstrated Il-15 dependent  CD4+ 
memory T  cell proliferation initiated by stressed 
DC (7). In an attempt to ascertain a  requirement 
for the IL-1/IL1βR  pathway, DC were treated 
with IL-1βR antagonist without or with IL-15 
antibodies in addition to the stress agents, 
followed by co-culture with autologous PBMC. 
The results suggest that Gramicidin required 
both  pathways, as only the combination of IL-
15 antibodies and IL-1βΡ antagonist 
significantly inhibited CD4+CD45RO+ memory 
or CD4+CD45RO+CCR7- effector memory T 
cells. However, Na arsenite and dithiocarbamate 
downregulated these memory cells with either of 
the two inhibitors. Alum also showed optimum 
inhibition with both inhibitors. These results are 
consistent with the paradigm that both H and I 
pathways may be involved in eliciting optimum 
CD4+CD45RO+ memory or CD45RO+CCR7- 
effector memory T cells.   
The effect of  one of the stress agents  
(Gramicidin)  was then studied on gene 
expression by microarray analysis of human 
CD4+CD45RO+ memory T cells.  The most 
striking finding was upregulation of  47 type 1 
IFN stimulated genes (ISG) which promote 
innate and adaptive immunity.  This is a novel 
and potentially important finding of cellular 
stress eliciting ISGs in CD4+ memory T cells. 
ISGs control a number of viruses at any stage of 
their replicative cycle.  There is ample evidence 
that a combination of ISG is more effective than 
any single ISG in controlling post-entry viral 
replication. Recently APOBEC3G and F, 
Tetherin (BST2), Trim5α and MX2 have been 
identified as retrovirus restriction factors, 
especially in CD4+ T cells (34,35). Type 1 IFN 
also stimulates APOBEC3G, 3F and 3A 
production in macrophages where it may prevent 
Vif neutralization of APOBEC (36). However, 
anti-HIV-1 function of APOBEC3A seems to be 
confined to the myeloid cells (37). Other 
restriction factors, such as MX1, IFIT and 
ISG15 inhibit influenza A viruses, and MX1, 
IFI44L, OAS2, RSAD2 may inhibit hepatitis C 
virus.  
Type 1 IFNs are most likely produced by  DC, 
especially plasmacytoid  DC and macrophages 
(). We addressed this issue in vivo by treatment 
of  BALB/c  mice with OVA, without or with 
the stress agents and studied 3 subsets of CD11c 
DC. IFNα was upregulated significantly in the 
CD11c CD317+ subset (p<0.0005), consistent 
with the literature, as these are plasmacytoid  
DC. However, stress also  increased  the CD8α+ 
subset (p<0.05), which has not been reported. 
They inhibit TH2 cytokines but stimulate TH1 
cytokines, as found in this work. They activate 
maturation of DC, induce antigen processing and 
presentation to T cells, CD8+ T cell cross-
presentation and CD4+ T cell responses  
(38,39).Whereas IFNα mediated  IL-15/IL-15R 
pathway stimulates, IL-1β/IL1βR inhibits 
CD4+memory T cell expression (40,41). 
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The question whether  DC- CD4+T cell direct 
contact was essential for stress-activated DC 
cells  to induce the memory cells was 
studied with stress stimulated DC in parallel  
with DC-derived culture supernatants , each co-
cultured with CD4+ T cells, followed  by assay 
of  CD4+ T cell proliferation. Significant  
proliferation was found in co-cultures with DC 
(37.0 ±3.0 %), but not  with the culture 
supernatant (5.0±1%), suggesting that  CD4+ 
memory T cells are cell to cell contact 
dependent. This finding may be of particular 
significance, as cell to cell transfer of  HIV may 
represent an escape strategy from innate host 
defence (42).  
Another cluster of upregulated genes show 
transcriptional regulatory activity, of which IFN 
regulating factors, IRF1 and IRF7 are upstream 
regulators of many ISGs.  They are master 
transcription factor genes, which are 
significantly upregulated by vaccination (43), as 
well as by adjuvants (44). Interestingly, these 
two transcriptional factors of ISG were also 
found with the powerful MF59 and CPG 
adjuvants (44). We have detected increased 
expression of BATF3, ATF5 and JDP2  with the 
stress agent (Gramicidin)  exposed cultures. 
These findings are noteworthy because BATF3 
and ATF are upstream regulators of RORγt and 
many other genes in the Th17 lineage; and 
BATF deficient mice lack Th17 cells (45). The 
elevated expression of these genes may 
contribute to the observed increase in the Th17 
cells. Since BATF and IRFs have also been 
shown to interact functionally it is likely that 
BATF family in association with IRF1 and IRF7 
may play a role in transcription regulation of the 
differentially regulated ISGs in this study. 
Gramicidin also induced early complement 
components and proteins of inflammasomes. 
We suggest that the widely held view 
that immunological memory is maintained by 
tonic stimulation of the homeostatic pathway 
might be due to repetitive cellular stress to 
which DC cells are exposed. These may activate 
the dual homeostatic and inflammasome 
pathways between the IL-15 and IL1β molecules 
expressed by DC and their respective receptors 
expressed by CD4+ T cells, with optimum 
expression of memory CD4+ T cells requiring 
both pathways (Fig. 2D). This raises an 
important issue, whether stress-activated, 
antigen independent memory is part of innate 
immunity, which maintains clones of existing 
antigen specific memory T cells. Both pathways 
may self-regulate the stress-induced memory T 
cells, by the downregulated CD4+ 
CD25+FoxP3+, enhancing immune functions. 
These cells are further inhibited by type 1 IFN 
(46). Furthermore, IL-6 may inhibit 
TGFβ induced T regulatory cell differentiation 
(47). IFN-α also inhibits caspase-1 and IL-1β 
pathway (41), but enhances the Th1 cytokines.  
The cellular stress response to tryptophan 
depletion by GEN-2 (general control of non-
derepressible-2-kinase), which is activated by 
the upregulated  enzyme IDO (indoleamine 2-3 
diogenase), regulates IFN-α production (48), 
and interacts through Jak/STAT signalling to 
induce ISG in the CD4+CD45RO+ memory T 
cells. IDO may also be involved in microbial 
infections.  CD40L which binds CD40 may 
activate DC in a positive feed-back loop.  The 
net outcome of the positive and negative 
feedback is difficult to predict, but both the 
direct evidence and inhibition studies are 
consistent with the concept that tonic stimulation 
by the stress agents may maintain a steady state 
of CD4+ memory T cells. 
Recent studies suggest that commensal 
bacteria which colonize the gut, upper 
respiratory system and vagina may provide tonic 
stimulation of the innate immune system and 
elicit optimal antiviral immunity (49,50) . 
Among the multitude of antigens in microbes 
LPS in Gram - negative bacteria and HSP in 
most microbes are potent stimulators of innate 
and adaptive immunity (7,8,51-54). We suggest 
that tonic microbial stimulation and that by 
stress agents may share a common mechanism 
outlined in the present investigation. 
 A comparison of the above stress-
induced signatures with the polyfunctional 
response elicited by the powerful yellow fever 
vaccine demonstrated a surprising degree of 
similarity between them (43). Both stress and the 
yellow fever vaccine induce innate immunity, 
complement components, interferon-stimulated 
genes, and inflammasomes. Adaptive immunity 
again is induced by both stress and the vaccine 
in T and B cell responses, though the latter is not 
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the subject of this paper. Finally, the two diverse 
stimulating agents upregulated specific 
transcription factors, of which IRF7 is shared by 
them, and may precede the development of the 
broad immune response. We suggest the 
paradigm that cellular stress might be 
responsible for the robust persistence of the 
immune response in vaccination. This will have 
to be demonstrated by immunization with an 
antigen to which the animal had not been 
exposed, followed by repeated treatment with a 
stress agent and then testing if the specific 
response is recalled longitudinally. 
The data also raised the question, 
whether repetitive DC - T cell exposure to stress 
might elicit epigenetic changes, thereby 
maintaining antigen-independent memory T 
cells. Preliminary studies demonstrated that 
expression of a number of genes were inhibited 
by MTA, shown by flow cytometry and RT-
PCR. This included IFN-γ and IL-17, produced 
by CD4+ memory T cells and was confirmed by 
RNA microarrays, which demonstrated 
inhibition with MTA in 14/23 ISGs upregulated 
by the stress agent. Epigenetic modifications 
have been suggested to be responsible for the 
differentiation of T helper lineage, involving 
demethylation of DNA and acquiring permissive 
histone modifications (55,56). This may apply 
especially to the differential regulation of Th1 
(IFNγ) and Th2 (IL-4) genes. The present results 
suggest that during stress responses, histone 
methyl transferase activity is involved in 
increased transcription of ISGs. MTA can block 
methylation of lysine 4 on histone H3 and this 
post-transcriptional modification is a 
determinant of the level of gene expression (57). 
Since H3K4me3 levels at transcriptional start 
sites of genes are related to the level of gene 
expression (58) and MTA can block 
trimethylation of H3K4, we postulate that stress 
induced by Gramicidin may influence 
transcription of upregulated genes via a histone 
methyl transferase. Our data suggest that stress 
may influence the chromatin environment, 
which comprises both histone and DNA 
components and elicit epigenetic changes, which 
maintain antigen independent memory.   
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Legends to Figures 
Table 1. Microarray analysis of CD4+CD45RO+ memory T cells. These cells were tested from 3 subjects  
by the Illumina platform following co-culture of PBMC with Gramicidin treated DC and validated by the 
Affymetrix platform with cells from 3 other subjects. Group 1A, B, C consists of 47 IFN stimulated 
genes, of which 1A, 1B and group 2 were also subjected to methylation inhibition by MTA. Group 2 
shows transcription factor genes (n=6), Group 3 complement genes (n=3), and Group 4 miscellaneous 
genes (n=4) (NI=Not identified; NC=No change). 
 
Fig. 1. Stress agents stimulate human monocyte derived DC to upregulate ROS, HSP70, . The optimum 
concentration of the stress agents used were Na arsenite (As, 50µM), Gramicidin (Gr, 2µM), 
dithiocarbamate (DITH, 1µM) or Alum (1%), which upregulated (A) ROS, (B flow cytometry), (C) IC 
HSP70, (D) flow cytometry, (E,F) cell surface HSP70.(G) HSP70 mRNA. All experiments were 
performed with 6 different samples of blood.  * p<0.05,  ** p<0.01, ***p<0.001. 
Fig.2.  The gating strategies used in this study are as follows. (A) Cell surface molecule staining of the 
live lymphocyte population was gated and confirmed by 7AAD negative staining. CD4+ T cells were then 
gated for cell surface molecules and/or CD45RO+ memory T cell. (B) For intracellular staining, cells were 
first stained for cell surface markers, followed by fixation and permeabilization. The lymphocyte 
population was then gated, CD4 naïve and memory T cells were identified and various intracellular 
proteins were examined within the identified CD4+, CD45RO+ central (CCR7+) or effector (CCR7-) 
memory T cells. (C) Culture of DC or (D) DC co-cultured with isolated CD4+ T cells were gated, based 
on FSC and SSC and these populations were examined for cell surface or intracellular molecules. (E) 
Schema of the dual stress-activated pathways, leading to CD4+CD45RO+ memory T cells, cytokines and 
IFN stimulated genes. 
Fig. 3 Dose dependent increase of the stress agents Na arsenite , Gramicidin and dithiocarbamate and 
Alum on (A) maIl-15 expression, (B) caspase-1 activation and (C) IL-1β in human monocyte derived DC 
(n=6). (D) Flow cytometry illustrations of maIl-15 elicited by treatment of the DC with the stress agents. 
The concentrations of caspase-1 and IL-1β showed similar patterns with the stress agents, but Alum 
differed. 
Fig.4  The effect of inhibition by N-acetylcystein (NAC),     without NAC,   with 5 µM NAC on 
stress-induced (A) maIL-15, (B) caspase-1 and (C) IL1β.   Stress mediated expression of IL-1βR  Stress 
upregulates IL-1βR only in CD45RO+ memory and not in naive CD45RO- CD4 T cells (D,E).  
 
Fig. 5 Co-culture of stress-treated DC with autologous PBMC induce CD40L and CD45RO+ memory in 
CD4+ T cells. These are significantly inhibited with both IL-15 antibodies and IL-1β  antagonists with all 
stress agents.  For optimum expression of human CD45RO+ or CD45RO+CCR7- memory T cells, both the 
homeostatic and inflammasome pathways have to be activated. To determine the role of IL-15 and IL-1β 
on CD40L expression in DC-PBMC co-cultures, IL-15 antibodies and IL-1β antagonist or both were 
added to the cultures treated with Na arsenite, Gramicidin, dithiocarbamate and Alum. (A) CD4+ T cell 
proliferative  responses performed by the CFSE method. (B) CD40L expression in CD4+ T cells co-
cultured with autologous DC, activated with the stress agents and treated with IL-15 antibodies, IL-1βR 
antagonist or both. Similarly, isotype  control antibody showed no difference from the untreated cells (not 
presented). (C) Representative flow cytometry.  Similarly the two pathways were studied for (D) 
CD45RO+ memory and (E) CD45RO+CCR7-  effector   memory  CD4+   T cells  inhibitions . Thus, all 
stress agents upregulated CD4+ and CCR7- memory T cells and optimum inhibition resulted when both 
inhibition agents were used.  T test was used for the  inhibitions  against untreated cultures *p<0.05, 
**p<0.01, ***p<0.001; and those of stress treated against untreated DC  ¥<0.05, ¥¥¥<0.001 (n=4);  DC,  
Fig. 6. The stress agents upregulate T- bet and RORγt and downregulate  FoxP3. To study  the effect of 
stress agents on the  transcription factors  human DC were treated with stress agents for 90 min, followed 
by co-culture  with autologous  PBMC  for 5 days.  Expression of (A,D) T-bethigh  IFNγ (B,E) RORγt and 
(C,F) FoxP3+ CD4+ Treg cells induced  by immature DC, LPS matured DC (mDC) or DC treated as 
16 
 
above  but co-cultured  with autologous CD4+T cells for 5 days in the presence of anti-CD3 (10ng/ml) 
and anti-CD28 (10ng/ml). ANOVA was used for each transcription factor in 5-6 groups, followed by the 
t- test for each stress treated group against DC alone (n=5). * p<0.05, **p<0.01, ***p<0.01.  Gata 3 
transcription of Th2 showed no change with the stress agents. (D) Production of IL-12p70 , (E) IL17 
producing CD4+ T cells after co-cultures were treated with anti-CD3 and CD28 antibodies, followed by 
PMA and ionomycin,  (F) IL-6 in the culture supernatant  from DC only  or co-cultured CD4+ T cell 
supernatant  (n=3-5).  
Fig. 7. (A) Production of IL-12p70 , (B) IL17 producing CD4+ T cells and (C) IL-6 in the culture 
supernatant  from DC only  or co-cultured CD4+ T cell supernatant  (n=3-5). For induction of IL-17 
producing cells co-cultures of CD4+ T cells and stress agents treated DC were treated with anti-CD3 and 
CD28 antibodies, followed by PMA and ionomycin, (D) stress treated DC mediated IL-6R upregulation 
and (E) representative flow cytometry of IL-6R expression in CD4+ T cells.   
Fig. 8 (A) Heat map of human CD4+CD45RO+ memory T cells following co-culture of Gramicidin-
treated DC with PMBC demonstrating upregulation of IFN stimulated genes. RNA was prepared from 3 
independent human samples (B-J). The Effect of MTA on Gramicidin stimulated DC co-cultured with 
PMBC: (B,C,D) mRNA of IFN-g, IL-17 and HSP70 in CD4+CD45RO+  T cells, (E,H)  intracellular IFN-γ  
and IL17 production , (F-J) CD4+ CD45RO+  and CD45RO- T cells  (n=3-6); *p<0.05, **p<0.01. The 
data suggest that stress may influence the chromatin environment and elicit epigenetic changes. 
Fig. 9 Effect of stress agents on expression of splenic CD11c DC subsets and IFN-α production in 
corresponding cells in BALB/c mice. Mice were treated with 3 stress agents and alum 3 times at two 
weeks interval. 1 week after final treatment, splenic cells DC subsets were analysed for expression of (A) 
CD11c, or in combination with (C) CD8α, (E) CD19,  (G) CD317.  Intracellular IFN-α was also measured 
in the corresponding DC subsets (B, D, F, H).  
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Table 1 
Group 1A Microarray platform   Group 1C Microarray 
platform 
 
Genes  
(n=16) 
Illumina 
p<0.05-
0.01 
Affym. MTA   (n=21) 
 
Illumina 
P<0.05 
 
 Interferon stimulated genes  IFN stimulated genes  
MX1 3.38 1.8 -0.8  FAM26F 2.2  
MX2 2.0 1.4 -0.2  EPST11 1.8  
APOBEC3A 4.70 2.0 -11.4  KIAA1618 1.8  
IRF7 2.1 2.2 -0.9  XAF1 1.8  
IRF1 1.6 1.4 -1.4  GRIN3A 1.7  
IFITM1 1.9 1.2 -0.9   RHOLL 1.7  
IFITM2   - 1.4 -1.5  MEFV 1.7  
IFITM3 1.8 1.8 -1.5  CD300LF 1.7  
0AS2 1.7 2.1 -0.33  PLEKHO1 1.6  
IFI35 2.0 2.1 -3.1  HMFO 1.6  
OAS3 1.60 2.0 -3.0  LOC1001330 1.6  
CBS 2.1 2.1 -3.2  ALDH1A1 1.6  
LILRA5 1.9 1.6 -0.2  PARP10 1.6  
AARS 1.9 1.6 -0.8  GFRA2 1.6  
SC02 1.8 1.6 -1.2  ACSL1 1.6  
SLC6A12 1.8 1.7 +1.9  SESN2 1.6  
     WARS 1.5  
Group 1B Interferon stimulated genes  RBCK1 1.5  
Genes 
(n=10) 
Illumina 
P<0.05 
Affym. MTA  STAC 1.5  
 DDX20 1.5  
IF144L 2.0 4.2 -3.4  ECGF1 1.5  
IFIT1 2.3 5.2 -3.0     
IFIT2 1.9 3.5 -2.0    
ISG15 2.3 2.1 -1.2  Group 3  (n=3) Complement Genes 
IFI44 2.2 1.7 +1.4   Illumina Affym. 
IFI27 3.3 6.8 -9.7  CIQC2 1.5  
RSAD2 2.2 2.0 -4.8  C2 2.0 NI 
HERC5 1.9 2.2 -1.7  CFB 1.6 1.8 
ID01 2.3 1.9 -8.6     
BST2   - 3.3 -1.3     
       
Group 2   Transcription factor genes  Group 4 Miscellaneous genes 
Genes (n=6) Illumina Affym. MTA   Genes (n=4) Illumina Affym. 
IRF1 1.6 1.3 -1.3  p38 (MAPK11) NC 8.0 
IRF7 2.0 2.2  0.9  Jak2 1.6 1.2 
BATF3 1.5 1.8 -1.3  TGFβ NC 4.4 
Tbet NC 1.8  -1.8  CLCN7 1.7 NC 
ATF5 1.5 NC NC     
NFκB NC 5.25  -4.2     
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